Networking and exploring advancements at Informa's 2024 Rare Disease Summit

Blog BI rare disease summit

Next month, BrightInsight will be heading to Philadelphia for Informa's 2024 Rare Disease Summit. It's an exciting opportunity to connect with thought leaders and stay current with the latest solutions and breakthroughs in the rare disease space.

I am excited to network with industry leaders, speakers and attendees who represent a wide variety of roles, from product launch and marketing professionals to patient advocacy and support experts.

BrightInsight has a special focus on regulated digital health solutions for rare diseases. Our Disease Management Solution helps biopharma companies augment their novel therapies through the power of digital, delivering better care in the rare disease space.

For example, we’ve partnered with CSL Behring to launch products that support patients throughout their journey. These include HEMGENIX®️, a groundbreaking app designed to support hemophilia B patients as they embark on gene therapy and the Hizentra app, which helps patients living with primary immune deficiency (PI) or chronic inflammatory demyelinating polyneuropathy (CIDP) navigate their treatment.

As a leader in this industry, it's important for BrightInsight to keep a finger on the pulse of the latest advancements in rare diseases. Events like the Rare Disease Summit are key.

Interested in networking with us at the summit? Find time in my calendar here.

To learn more about BrightInsight's work in the rare disease space, check out our website.

Back to Blog